Drug shortage: Dobutamine Hydrochloride Injection (DOBUTAMINE IN DEXTROSE, DOBUTAMINE, DOBUTAMINE HYDROCHLORIDE IN DEXTROSE)
FDA lists 10 presentations as Current. Availability: Unavailable (1), Available (9). Reason: Other. Companies: Hospira, Inc., a Pfizer Company, Baxter Healthcare, Hainan Poly Pharm. Co., Ltd..
- Published by source
- 2017-11-06
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Products
- Dobutamine Hydrochloride Injection DOBUTAMINE IN DEXTROSE DOBUTAMINE DOBUTAMINE HYDROCHLORIDE IN DEXTROSE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay
- Distributed by Slate Run Pharmaceuticals, LLC, 1-844-529-8988
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2017-11-06
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #914 | new | 2026-10-22 | fbbca1544e06…5d7baf | ce1651b02de9…cfd54b |
Chain head: #1076 8ad5adc30b9b…88ce20